Early detection and treatment of congenital hypothyroidism (CH) through neonatal screening prevents neurodevelopmental disability and optimizes developmental outcomes Earlier diagnosis and treatment was more important than increase in dose Start treatment with higher dose high LT4 starting doses rapidly normalize serum TSH concentrations resulting in an improvement of the IQ at 4 years of age, even in patients with severe CH at diagnosis Many studies have confirmed the early success of CH screening for Grade 1 normalizing the cognitive outcomes of children with severe primary recommendation CH, and the timing of the normalization of thyroid function may influence the outcome Review of 11 Infants started "early" (12 to 30 days of age) had a mean intelligence studies quotient (IQ) 15.7 points higher than infants started "later" (>30 days of age)
The most sensitive test for detecting primary CH is TSH determination Optimal global IQ (GIQ; 119+/-1.8) was obtained for a recall < or DESCRIPTIVE =15 days. Results for a recall after 3 weeks were lower (107.7 +/-STUDY 2.4). effect of different starting L-T4 doses on psychometric outcome. A review of ten Two of the studies reported no effect, while six reported that lower studies starting doses resulted in lower IQ outcome, averaging 12.3 points in another analytic study, group 1 (n = 42) received the previously recommended dose of 6. In one small study, patients who took longer than two weeks to normalize their thyroid function had lower cognitive, attention, and achievement scores than those who achieved normal function within two weeks after therapy was started, full-scale IQ scores were 11 points higher in those started on 50 mcg/day versus 37.5 mcg/day high versus low starting dose of L-T4 (~ or <9.5 mcg/kg per day). In infants with more severe hypothyroidism, only those treated early with high-dose L-T4 achieved normal psychomotor development at 10 to 30 months longitudinal growth and intelligence quotient (IQ) at 4 years of age in 83 patients with CH 
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Infants who have serum T4 concentrations below 10 mcg/ dL (129 nmol/L) in the first year of life, particularly if accompanied by serum TSH concentrations above 15 mU/L, will have lower IQs than infants whose serum T4 concentrations are above 10 mcg/ dL (129 nmol/L) Persistently high serum T4 or fT 4 concentrations for age, especially if T4 is above 16 mcg/dL (206nmol/L) orfT4 above 2.4 ng/dL (30.5 pmol/L), may adversely affect the tempo of brain development, have adverse effects on cognitive development, temperament or attention span, and cause premature craniosynostosis A strategy of second screening should be considered for the following conditions : preterm neonates; low-birth weight (LBW) and very lowbirth weight (VLBW) neonates; ill and preterm newborns admitted to neonatal intensive care units (NICU); specimen collection within the first 24 hours of life; and multiple births (particularly same-sex twins) hearing impairment (9 .5 vs. 2.5%) , visual problems (55.4 vs. 47.9%), and being overweight with a body mass index of at least 25 kg/m(2) (22.8 vs . 15. 7%) (P < 0.0001) babies were more in with CH visual processing problems (not just visual acuity) fewer patients attained the highest socioeconomic category (14.6 vs. 23.1 %) and were in full -time employment (39 .9 vs. 44.8%) (P < 0.0001).
They were more likely to still be living with their parents and had a lower health-related quality of life than their healthy peers, particularly for mental dimensions, w ith a mean difference for the mental summary component of 0.35 SD score (P < 0.0001 ). 
